Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Papillomavirus Infections 9Warts 2Uterine Cervical Neoplasms 2Condylomata Acuminata 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Dysplasia 1Neoplasms 1High Grade Anal Canal Intraepithelial Neoplasia 1Hematologic Neoplasms 1HIV Infections 1Cancer Survivor 1

Interventions

Cryotherapy 11Salicylic Acid 3PRA1 protein, Candida albicans 3Cholecalciferol 3Cantharidin 3Tuberculin 2Solutions 2Sodium Chloride 2Saline Solution 2Percutaneous Collagen Induction 2Measles-Mumps-Rubella Vaccine 2Lasers 2Hydrogen Peroxide 2Human Papillomavirus Recombinant Vaccine nonavalent 2leupin 1lactic acid, salicylic acid drug combination 1green tea extract polyphenone E 1Zinc Sulfate 1Zinc 1Vitamin D 1Vaccination 1Trichloroacetic Acid 1Pyruvic Acid 1Photochemotherapy 1Methylene Blue 1Mass Screening 1Lasers, Solid-State 1Lasers, Gas 1Laser Therapy 1Ivermectin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Warts × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

NCT05625633 2024-04-05

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Western Institute for Veterans Research

Phase 2/3 Recruiting
120 enrolled

Warts, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡